Group I Paks as therapeutic targets in NF2-deficient meningioma

Author:

Chow Hoi-Yee1,Dong Biao2,Duron Sergio G.3,Campbell David A.3,Ong Christy C.4,Hoeflich Klaus P.4,Chang Long-Sheng567,Welling D. Bradley7,Yang Zeng-jie1,Chernoff Jonathan1

Affiliation:

1. Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA

2. Department of Microbiology and Immunology, Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, Pennsylvania 19104, USA

3. Afraxis Inc., La Jolla, California 92037, USA

4. Department of Translational Oncology, Genentech, South San Francisco, California 94080, USA

5. Center for Childhood Cancer, The Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio 43205, USA

6. Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio 43205, USA

7. Department of Otolaryngology, The Ohio State University College of Medicine, Columbus, Ohio 43205, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3